A high-capacity scintillation proximity assay for the discovery and evaluation of ZAP-70 tandem SH2 domain antagonists

Journal of Biomolecular Screening

Volumn 3, Issue 2, 1998, Pages 139-144

  Sheets, Michael P ^a   Warrior, Usha P ^a   Yoon, Hosup ^a   Mollison, Karl W ^a   Djuric, Stevan W ^a   Trevillyan, James M ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000598101     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705719800300208     Document Type: Article

References (25)

1. Weissman, A.M., Hou, D., Orloff, D.G., Modi, W.S., Seuanez, H., O'Brien, S.J., Kluasner, R.D. (1988). Molecular cloning and chromosomal localization of the human T cell receptor ζ chain: Distinction from the molecular CD3 complex. Proc. Natl. Acad. Sci. U.S.A. 24:9709-9713.
2. Strauss, D., Weiss, A. (1992). Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585-593.
3. Danielian, S., Alcover, A., Polissard, L., Stefanescu, M., Acuto, O., Fischer, S., Fagard, R. (1992). Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p561ck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p561ck. Eur. J. Immunol. 22:2915-2921.
4. Burkhardt, A.L., Stealy, B., Rowley, R.B., Mahajan, S., Prendergast, M., Fargnoli, J., Bolen, J.B. (1994). Temporal regulation of non-transmembrane protein tryosine kinase enzyme activity following T cell antigen receptor engagement. J. Biol. Chem. 269:23642-23547.
5. Thome, M., Germain, V., DiSanto, J.P., Acuto, O. (1996). The p561ck SH2 domain mediates recruitment of CD8/p561ck to the activated T cell receptor/CD3/ζ complex. Eur. J. Immunol. 26:2093.
6. lck) that phosphorylates the CD3 complex. Proc. Natl. Acad. Sci. U.S.A. 86:3277-3281.
7. Reth, M. (1989). Antigen receptor tail clue. Nature 338:383-384.
8. Isakov, N., Wange, R.L., Burgess, W.H., Watts, J.D., Aebersold, R., Samelson, L.E. (1995). ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: The tendem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity J. Exp. Med. 181:375-380.
9. Hatada, M.H., Lu, X., Laird, E.R., Green, J., Morgenstern, J.P., Lou, M., Marr, C.S., Phillips, T.B., Ram, M.K., Theriault, K., Zoller, M.J., Karas, J.L. (1995). Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T cell receptor. Nature 377:32-38.
10. Letourneur, F., Klausner, R.D. (1992). Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 ε. Science 255:79-82.
11. Romeo, C., Amiot, M., Seed, B. (1992). Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor ζ chain. Cell 68:889-897.
12. Irving, B.A., Chan, A.C., Weiss, A.J. (1993). Functional characterization of a signal transducing motif present in the T cell antigen receptor ζ-chain. J. Exp. Med. 177:1093-1103.
13. Neumeister, E.N., Zhu, Y., Richard, S., Terhorst, C., Chan, A.C., Shaw, A.S. (1995). Binding of ZAP-70 to phosphorylated T cell receptor ζ and η enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol. Cell. Biol. 15:3171-3178.
14. Arpaia, E., Shahar, M., Dadi, H., Cohen, H., Roifmen, C.M. (1994). Defective T cell receptor signaling and CD8+ thymic selection in humans lacking ZAP-70 kinase. Cell 76:947-958.
15. Elder, M.E., Lin, D., Clever, J., Chan, A.C., Hope. T.J., Weiss, A., Parslow, T.G. (1994). Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264:1596-1599.
16. Chan, A.C., Kadlecek, T.A., Elder, M.E., Filipovish, A.H., Kuo, W.-L., Iwashima, M., Parslow, T.G., Weiss, A. (1994). ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264:1599-1601.
17. Elder, M.E., Hope, T.J., Parslow, T.G., Umetsu, D., Wara, D.W., Cowen, M.J. (1995). Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency. Cell. Immunol. 165:110-117.
18. Negishi, I., Motoyama, N., Nakayama, K., Nakayama, K., Senju, S., Hatakeyama, S., Zhang, Q., Chan. A.C., Loh, D.Y. (1995). Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376:435-438.
19. Wange, R.L., Guitian, R., Isakov, N., Watts, J.D., Aebersold, R., Samelson, L.E. (1995). Activity and inhibitory mutations in adjacent tyrosines in the kinase domain ZAP-70. J. Biol. Chem. 270:18730-18733.
20. Wange, R.L., Isakov, N., Burke, T.R. Jr, Otaka, A., Roller, P.P., Watts, J.D., Aebersold, R., Samelson, L.E. (1995). F2(Pmp)2-TAM ζ3, a novel competetive inhibitor of the binding of ZAP-70 to the T cell antigen receptor, blocks early T cell signaling. J. Biol. Chem. 270:944-948.
21. Chen, T., Repetto, B., Chizzonite, R., Pullar, C., Burghardt, C., Dharm, E., Zhao, Z., Carroll, R., Nunes, P., Basu, M., Danho, W., Visnick, M., Kochan, J., Waugh, D., Gilfillan, A.M. (1996). Interaction of phosphorylated FcεRIγ immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics. J. Biol. Chem. 271:25308-25315.
22. Labadia, M.E., Ingraham, R.H., Schembri-King, J., Morelock, M.M., Jakes, S. (1996). Binding affinities of the SH2 domains of ZAP-70, p561ck and She to the ζ chain ITAMs of the T cell receptor determined by surface plasmon resonance. J. Leukoc. Blol. 59:740-746.
23. src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance. Proc. Natl. Acad. Sci. U.S.A. 90:4902-4906.
24. Koh, W.S., Yoon, S.Y., Lee, E.K., Kwon, B.W., Kim, J.W., Han, M.Y. (1997). A screening method of SH2 domain ligands and blockers using a solid phase binding. Cancer Lett. 120:1-7.
25. Braunwalder, A.F., Wennogle, L., Gay, B., Lipson, K.E., Sills, M.A. (1996). Application of scintillation microtiter plates to measure phosphopeptide interactions with the GRB2-SH2 binding domain. J. Biomolec. Screen. 1:23.